ICH GCP R3 is now in English & EU languages. Book Now

About

The GCP & GMP Regulatory Inspection Readiness training course by Whitehall Training provides a high-stakes foundation for navigating global oversight in pharmaceutical development and manufacturing. Grounded in the latest ICH E6(R3) and ICH Q10 standards, the course prepares professionals to transition from basic compliance to a state of 'inspection readiness.' It dissects the enforcement powers of major agencies like the FDA, EMA, and MHRA, while clarifying legal frameworks such as 21 CFR Parts 210/211 and EU Regulation 536/2014. Participants learn to differentiate between GCP inspections, which focus on subject rights and data integrity, and GMP inspections, which center on product quality and manufacturing control. The curriculum details the full inspection lifecycle, from initial notification and opening meetings to investigator interviews and the critical close-out phase. A significant emphasis is placed on the FDA’s six-subsystem quality framework, finding categories (Critical, Major, Minor), and Corrective and Preventive Action (CAPA) systems. By integrating case studies on Form FDA 483s and data integrity violations, the course ensures that organizations can maintain a permanent state of control and effectively manage regulatory risk in a globalized industry.

Course Syllabus

  1. Why Regulatory Inspections Exist
  2. Legal Frameworks and Regulatory Authority
  3. What Triggers a Regulatory Inspection
  4. The Inspection Timeline
  5. GCP vs GMP Inspections

  1. The FDA BIMO Programme
  2. How FDA Selects Sites for Inspection
  3. The FDA Inspection Visit — Phase by Phase
  4. Form FDA 483 and Warning Letters
  5. Most Common BIMO Violations

  1. The EMA GCP Inspection Programme
  2. MHRA GCP Inspections Post-Brexit
  3. GCP Finding Categories and Regulatory Consequences
  4. Writing Effective Inspection Responses
  5. Escalation Pathways and Long-Term Impact

  1. ICH Q10 and Inspection Readiness
  2. Types of Regulatory GMP Inspections
  3. FDA's Quality Systems Inspection Approach
  4. Building Inspection Readiness at GMP Sites
  5. When GCP and GMP Intersect

Our Certified Customers

novartis
NHS
takeda
roche
baxter

Learner Rating & Reviews

4.7
Average Rating
536 global ratings
87.0%
5.0%
3.0%
3.0%
2.0%
RC

Working with Whitehall training for the last two years of partnership has been a very successful experience – I have fast access to all the GCP course...

SM

I have finalised the demo for the ICH-GCP E6 R3 refresher course. Overall, I liked the content and the interface. I also want to thank Whitehall Train...

Frequently Asked Questions

The curriculum details the full inspection lifecycle, from initial notification and opening meetings to investigator interviews and the critical close-out phase. A significant emphasis is placed on the FDA’s six-subsystem quality framework, finding categories (Critical, Major, Minor), and Corrective and Preventive Action (CAPA) systems.

This course provides a practical understanding of how to prepare for and manage regulatory inspections across both Good Clinical Practice (GCP) and Good Manufacturing Practice (GMP) environments. You will learn how to interpret regulatory expectations, maintain inspection-ready documentation, handle auditor interactions with confidence, identify compliance gaps, and implement effective corrective and preventive actions (CAPAs). The course also covers real-world inspection scenarios, common findings, and strategies to ensure continuous inspection readiness.

This course is ideal for professionals working in clinical research, pharmaceuticals, and life sciences, including Clinical Research Associates (CRAs), Quality Assurance (QA) personnel, Regulatory Affairs professionals, Investigators, Study Coordinators, and GMP manufacturing staff. It is also suitable for anyone involved in audits, inspections, compliance management, or quality systems within regulated environments.

  • Gain end-to-end understanding of GCP and GMP inspection processes
  • Build confidence in handling regulatory inspectors and audits
  • Learn to identify and mitigate compliance risks proactively
  • Improve documentation practices and inspection readiness
  • Strengthen knowledge of CAPA planning and implementation
  • Enhance career prospects in quality, regulatory, and clinical roles